JNJ-38158471
CAS: 951151-97-6
Ref. 3D-BNB15197
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Informação sobre produto
JNJ-38158471 is a tyrosine kinase inhibitor that has been shown to have anticancer activity. It can be used for the treatment of cancers, including primary resistance. JNJ-38158471 modulates the activity of growth factors, such as vascular endothelial growth factor and hepatocyte growth factor, which are involved in tumor angiogenesis and tumor cell proliferation. This drug also interacts with factor receptors on cells, which may lead to the termination of their signaling pathways. The oral formulation of JNJ-38158471 has been found to be safe and well tolerated in preclinical studies in mice. This drug is also selective for cancer cells, not affecting normal cells.
Propriedades químicas
Consulta técnica sobre: 3D-BNB15197 JNJ-38158471
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
